References
Chalkidou A, Mikhaeel G, O’Doherty MJ, Marsden PK (2013) Letter to the editor re: positron emission tomography with [18F]-3′-deoxy-3′fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study. Mol Imaging Biol doi:10.1007/s11307-013-0628-9
Dehdashti F, Grigsby PW, Myerson RJ et al (2013) Positron emission tomography with [18F]-3′-deoxy-3′fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study. Mol Imag Biol 15:106–113
MacGregor TP, Maughan TS, Sharma RA (2012) Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now. J Clin Pathol 65:867–871
Aghili M, Izadi S, Madani H, Mortazavi H (2010) Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer. Asia Pac J Clin Oncol 6:35–41
Acknowledgments
We would like to thank Dr. Chalkidou et al. for their comments.
Conflict of Interest
None of the authors has a conflict of interest associated with this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dehdashti, F., Grigsby, P.W. & Siegel, B.A. Response to the Letter to the Editor Regarding the Manuscript Entitled “Positron Emission Tomography with [18F]-3′-Deoxy-3′Fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: A Pilot Study”. Mol Imaging Biol 15, 786–787 (2013). https://doi.org/10.1007/s11307-013-0663-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-013-0663-6